2026 NPPES data Family Medicine Physician NPI 1770891020 MD
Verify on CMS →

LAURA MANZANILLA LUBERTI, MD

Family Medicine Physician in EDINBURG, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 109 beneficiaries · Family Medicine Physician avg: 3K
Generic prescribing
82%
generic claims · 18% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
81.4423/100
▼ 2 pts below national avg 83.1 · [object Object]

What the federal data shows

LAURA MANZANILLA LUBERTI, MD reported a CMS MIPS final score of 81.4423/100 — below the 83.1 national average — and filed 1,803 Medicare Part D claims in 2023.

81.4423/100
MIPS score · -2 vs avg
2K
Part D claims, 2023
82%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

LAURA MANZANILLA LUBERTI, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

81 36th percentile higher than 36% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). This entry sits in this band. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

LAURA MANZANILLA LUBERTI, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about LAURA MANZANILLA LUBERTI, MD?

Near national average

NPI registry status

Active

Issued 09/21/2010

NPI 1770891020

Primary specialty

Family Medicine Physician

High-volume

147,640 US NPIs in this specialty

Medicare Part D claims

1,803 47% vs specialty avg

2023 prescription claims

Specialty avg: 3,418

MIPS final score

81.4423/100 1.6576999999999913% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Texas

How Family Medicine Physician compares to other specialties among Texas providers

Texas providers

Family Medicine Physician share within Texas

1. Family Medicine Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Family Medicine Physician share within Texas

Medicare quality performance — MIPS

LAURA MANZANILLA LUBERTI, MD's 2023 MIPS final score plotted against the Family Medicine Physician national average

Near national average
MIPS Final Score
81.4423/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Family Medicine Physician) — 81.4423/100 vs national avg 83.1

0%100%National avg83%81.4%
MIPS final score (Family Medicine Physician) — 81.4423/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

LAURA MANZANILLA LUBERTI, MD appears in the CMS NPPES registry as a Family Medicine Physician provider holding MD credentials at 3804 S JACKSON RD STE 2, EDINBURG, TX, 78539, with a listed phone of (956) 296-3021. NPI 1770891020 was issued on 09/21/2010. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MANZANILLA LUBERTI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,803 prescription claims written by this provider, covering 109 Medicare beneficiaries and totaling roughly $315K in drug spend, split 18% brand-name and 82% generic by claim count, with an opioid prescribing rate of 1.3%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 81.4423/100 for the 2023 performance year (Quality 65.8349, Cost 49.2365), compared with the national average of 83.1.

Family Medicine Physician is a high-volume specialty nationwide, with 147,640 enrolled providers across 56 states and an average of 3,418 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

3804 S JACKSON RD STE 2
EDINBURG, TX 78539

Provider Details

NPI 1770891020
Specialty Family Medicine Physician
Credentials MD
Gender Female
NPI Issued 09/21/2010

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

81.4423
Final Score
Avg: 83.1
65.8349
Quality
49.2365
Cost
98
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where LAURA MANZANILLA LUBERTI, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

UNIVERSITY OF TEXAS RIO GRANDE VALLEY
EDINBURG, TX

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

License & disciplinary context — Texas TMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to LAURA MANZANILLA LUBERTI, MD. To verify LAURA MANZANILLA LUBERTI, MD's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

LAURA MANZANILLA LUBERTI, MD — brand share 18.0%
Specialty average (est.)

18% brand-name claims vs 82% generic, on 1,803 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,803
Total Claims
$315K
Total Drug Cost
109
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
4,200
Total Day Supply
122,786
Brand vs Generic
18% brand / 82% generic
Brand Drug Cost
$274K
Generic Drug Cost
$40K
Opioid Claims
24 (1.3% rate)
Antibiotic Claims
33

Patient Demographics

Average Patient Age
70.5 years
Avg HCC Risk Score
1.50
Gender Split
65% female / 35% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What LAURA MANZANILLA LUBERTI, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Atorvastatin Calcium
111
Levothyroxine Sodium
66
Amlodipine Besylate
58
Losartan Potassium
57
Lisinopril
53
Rosuvastatin Calcium
46
Metoprolol Succinate
45
Fluticasone Propionate
42
Gabapentin
42
Metformin Hcl
40

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Family Medicine Physician Overview

How LAURA MANZANILLA LUBERTI, MD fits within the Family Medicine Physician landscape nationally.

147,640
Family Medicine Physician Providers in US
56
States with Family Medicine Physician
3,418
Avg Claims per Provider

LAURA MANZANILLA LUBERTI, MD's 1,803 claims are below the specialty average of 3,418.

Nearby Family Medicine Physician Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as MANZANILLA LUBERTI.

Compare Family Medicine Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is LAURA MANZANILLA LUBERTI, MD's specialty?
LAURA MANZANILLA LUBERTI, MD specializes in Family Medicine Physician and practices in EDINBURG, Texas. Credentials: MD.
How much does LAURA MANZANILLA LUBERTI, MD prescribe under Medicare Part D?
In 2023, LAURA MANZANILLA LUBERTI, MD wrote 1,803 Medicare Part D claims totaling $315K in drug costs for 109 beneficiaries.
What is LAURA MANZANILLA LUBERTI, MD's Medicare quality score?
LAURA MANZANILLA LUBERTI, MD has a CMS MIPS Final Score of 81.4423/100 (Quality: 65.8349, Cost: 49.2365). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is LAURA MANZANILLA LUBERTI, MD located?
LAURA MANZANILLA LUBERTI, MD is located at 3804 S JACKSON RD STE 2, EDINBURG, TX, 78539. Phone: (956) 296-3021.
What is LAURA MANZANILLA LUBERTI, MD's NPI number?
LAURA MANZANILLA LUBERTI, MD's National Provider Identifier (NPI) is 1770891020, issued on 09/21/2010.
Does LAURA MANZANILLA LUBERTI, MD prescribe more brand-name or generic drugs?
LAURA MANZANILLA LUBERTI, MD's prescribing is 18% brand-name and 82% generic drugs by claim count, with $274K in brand drug costs.
Does LAURA MANZANILLA LUBERTI, MD prescribe opioids?
Yes, LAURA MANZANILLA LUBERTI, MD had 24 opioid claims in 2023 with an opioid prescribing rate of 1.3%.
How many Family Medicine Physician providers are there in the US?
There are 147,640 Family Medicine Physician providers across 56 states in the US. The average Family Medicine Physician provider writes 3,418 Medicare Part D claims per year.
What drugs does LAURA MANZANILLA LUBERTI, MD prescribe most often?
Based on 2023 Medicare Part D data, LAURA MANZANILLA LUBERTI, MD's most frequently prescribed drugs include Atorvastatin Calcium, Levothyroxine Sodium, Amlodipine Besylate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does LAURA MANZANILLA LUBERTI, MD accept Medicare?
LAURA MANZANILLA LUBERTI, MD appears in CMS Medicare data with 1,803 Part D claims and 109 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify LAURA MANZANILLA LUBERTI, MD's credentials?
LAURA MANZANILLA LUBERTI, MD's NPI is 1770891020 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology